DynPort Vaccine Company

DynPort Vaccine Company is an American biotechnology company based in Frederick, Maryland. It is “dedicated to the development and licensure of safe and efficacious biodefense vaccines.”

DynPort was founded in 1997 as a joint venture between defense contractor DynCorp and Porton International, a wholly-owned subsidiary of Ipsen.^{1) 2)} That year, the United States Department of Defense (DoD), through its Joint Vaccine Acquisition Program (JVAP), contracted DynPort to manufacture 300,000 doses of a new smallpox vaccine for the military.³⁾

On March 30, 2004, Commonwealth Biotechnologies announced it had entered a partnership with DynPort through which the companies would “co-venture wherever appropriate to compete for new biodefense vaccine development funding.”⁴⁾

DynPort developed vaccines and related biologicals for a number of diseases including:⁵⁾

• Anthrax vaccine
• Botulinum multivalent vaccine
• Plague vaccine
• Smallpox vaccine
• Tularemia vaccine
• Vaccinia immune globulin
• Venezuelan equine encephalitis (VEE) vaccine

• LinkedIn
• SourceWatch
• Website (earliest archive)